Please log into your account for a discounted member rate!
Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)
This program will expire and must be completed by 10/28/27.
** Please note this program was a part of the VOC 2024. You will not want to choose this program if you completed this individual program as part of the VOC 2024. **
This presentation will discuss genetic testing. The common genetic testing resources that patients use will be discussed so attendees can become familiar with the testing available to their patients. How physicians can best use genetic testing to improve patient outcomes will also be discussed.
Objectives:
• Examine the different methods of clinical genetic testing and their roles and limitations
• Illustrate the role of pharmacogenetic testing
• Describe the role of NIPS/NIPT and its limitations
• Discuss the limitations of direct-to-consumer (DTC) testing
• Discuss basis of GWAS and polygenic risk scores
Accreditation Statements:
This program is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO). Both osteopathic associations are accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The program has been designated for a maximum of one (1) AOA Category 1-A Credit(s) by the co-sponsors who have authorized the Missouri Association of Osteopathic Physicians and Surgeons to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this conference for a maximum of one (1) AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The Virtual CME Committee consisting of representatives from the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO), has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of these presentations.
Osteopathic Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Dr. Yang Handout (2.24 MB) | 52 Pages | Available after Purchase |
Dr. Amy Yang is an Assistant Professor at Oregon Health and Science University (OHSU) in Portland, Oregon. She is a Clinical Geneticist and Pediatrician. She received her Doctor of Medicine from the NYU School of Medicine, now known as NYU Grossman School of Medicine, in 2006. Dr. Yang completed her residency training in Pediatrics and Genetics at the Mount Sinai Hospital in New York in 2009 and 2011, respectively. In 2016, she received the Medical Genetics Residency Teaching Award. Dr. Yang is board certified in Pediatrics by the American Board of Pediatrics and in Genetics by the American Board of Medical Genetics and Genomics.
Prior to her move to OHSU in 2018, Dr. Yang was an assistant director of the Medical Genetics Residency Program and an Associate Director of the Lysosomal Storage Disease Program at Mount Sinai Hospital. Currently, she is serving as the Medical Director of the Metabolic Genetics and Lysosomal Disease Program at OHSU. She is a Northwest Regional Newborn Screening Program consultant and is a member of their Advisory Board.
Dr. Yang was named a New York Rising Stars Super Doctor in 2018. In 2021, she was named Top Doctor by the Portland Monthly Magazine.
Dr. Yang loves hiking, spending time with her kitties, and trying new recipes in her free time.
Dr. Yang discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|